Flora Growth Corp. provided revenue guidance for the year 2023. The company announced revenue guidance of USD 90 million to USD 105 million for fiscal year 2023.

Flora's 2023 revenue guidance of $90 million to $105 million reflects expected organic growth in the House of Brands division and expansion of the Commercial & Wholesale division capabilities. This forecasted growth also incorporates Flora's new German-based business as established through the acquisition of Franchise Global Health. Flora's German operations solidify a crucial foothold in a growing international cannabis market, providing a unique opportunity for operational synergies and diversified growth.

Revenue growth is also expected to reflect the continued successful execution of product development and pricing strategies.